Literature DB >> 9666085

Effects of adrenal medullary transplants on pain-related behaviors following excitotoxic spinal cord injury.

K L Brewer1, R P Yezierski.   

Abstract

Previous studies have shown that intraspinal injection of quisqualic acid (QUIS) produces excitotoxic injury with pathological characteristics similar to those associated with ischemic and traumatic spinal cord injury (SCI). Significant changes in the functional properties of sensory neurons adjacent to the site of injury have also been observed in this model. Additionally, following QUIS injections, mechanical and cold allodynia, combined with excessive grooming behavior have been shown to be the behavioral correlates of these pathological and physiological changes. These behaviors are believed to be related to the clinical conditions of spontaneous and evoked pain following SCI. Given the therapeutic properties of adrenal chromaffin cell transplantation in conditions of neuropathic and cancer pain, it is proposed that the neuroactive substances released from chromaffin cells can alter or prevent the onset and progression of QUIS-induced behavioral changes. The effects of adrenal transplants were evaluated in 14 male Long-Evans rats that received intraspinal injections of QUIS. Pain behaviors, including the progression of excessive grooming behavior (n=8) and hypersensitivity to mechanical and thermal stimuli (n=6) were evaluated following transplantation. A 53% increase in mechanical thresholds was observed following adrenal transplants along with a 70% reduction in the area of skin targeted for excessive grooming. These behaviors were not affected in 11 animals receiving transplants of skeletal muscle. The effects of adrenal transplants on cold allodynia consisted of a stabilization of response latencies in contrast to the continued decrease in latencies, i.e., increased sensitivity, following transplants of skeletal muscle. The results are consistent with previous studies showing the therapeutic efficacy of adrenal chromaffin cell transplants in neuropathic pain, and support the use of this treatment strategy for the alleviation of chronic pain following spinal cord injury. Copyright 1998 Elsevier Science B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9666085     DOI: 10.1016/s0006-8993(98)00398-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Predifferentiated embryonic stem cells prevent chronic pain behaviors and restore sensory function following spinal cord injury in mice.

Authors:  Wesley A Hendricks; Elena S Pak; J Paul Owensby; Kristie J Menta; Margarita Glazova; Justin Moretto; Sarah Hollis; Kori L Brewer; Alexander K Murashov
Journal:  Mol Med       Date:  2006 Jan-Mar       Impact factor: 6.354

2.  Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury.

Authors:  J D Figueroa; K Cordero; M Serrano-Illan; A Almeyda; K Baldeosingh; F G Almaguel; M De Leon
Journal:  Neuroscience       Date:  2013-09-14       Impact factor: 3.590

3.  Long-term Follow-up of Cutaneous Hypersensitivity in Rats with a Spinal Cord Contusion.

Authors:  Ji-In Jung; Junesun Kim; Seung Kil Hong; Young Wook Yoon
Journal:  Korean J Physiol Pharmacol       Date:  2008-12-31       Impact factor: 2.016

4.  PTEN/PI3K and MAPK signaling in protection and pathology following CNS injuries.

Authors:  Chandler L Walker; Nai-Kui Liu; Xiao-Ming Xu
Journal:  Front Biol (Beijing)       Date:  2013-08-01

5.  Review of the history and current status of cell-transplant approaches for the management of neuropathic pain.

Authors:  Mary J Eaton; Yerko Berrocal; Stacey Q Wolfe; Eva Widerström-Noga
Journal:  Pain Res Treat       Date:  2012-06-14

6.  Predifferentiated GABAergic neural precursor transplants for alleviation of dysesthetic central pain following excitotoxic spinal cord injury.

Authors:  Jeung Woon Lee; Stanislava Jergova; Orion Furmanski; Shyam Gajavelli; Jacqueline Sagen
Journal:  Front Physiol       Date:  2012-05-31       Impact factor: 4.566

7.  Potential for Cell-Transplant Therapy with Human Neuronal Precursors to Treat Neuropathic Pain in Models of PNS and CNS Injury: Comparison of hNT2.17 and hNT2.19 Cell Lines.

Authors:  Mary J Eaton; Yerko Berrocal; Stacey Q Wolfe
Journal:  Pain Res Treat       Date:  2012-04-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.